Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases
Inflammopharmacology · 2026-02 · 34 (2) · 883-918
DOI: 10.1007/s10787-025-02069-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 18.12.2025. Verfasst von Radwa N Muhammad und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Biological Products, Noncommunicable Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 341 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Non-communicable diseases, such as diabetes, cancer, as well as cardiovascular, metabolic, and central nervous system disorders stand for significant global health burden. Statins, as HMG-CoA reductase inhibitors, have emerged as a basis in the management of hypercholesterolemia and the prevention of cardiovascular disorders. In this review, we summarize the role of statins in a variety of pathologies, ranging from their well-recognized effects in cardiovascular disorders, to the newly revealed favorable effects in cancer, eye, autoimmune, kidney, gastrointestinal, bone, and autoimmune disorders. Additionally, the current review explores insights into the potential role of natural products as HMG-CoA reductase inhibitors. Future research should focus on the synergistic effects of natural therapies with synthetic statins to improve health outcomes in populations burdened by non-communicable diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Ahram Canadian University, Giza, 12566, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, 11829, Egypt.
- Therapeutic Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Center, Dokki, Giza, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, 12566, Giza, Egypt.
Förderung
- Cairo University
Zitieren
APA
Muhammad, R. N., Aborehab, N. M., Aly, S. H., Nasr, N. N., Hindam, M. O., Mustafa, A. M., Faheem, S. A., Fawzy, M. H., Abo-El Fetoh, M. E., El-Dessouki, A. M., Rabie, M. A., El-Shiekh, R. A., & Youssef, M. E. (2026). Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases. Inflammopharmacology, 34(2), 883-918. https://doi.org/10.1007/s10787-025-02069-2
Vancouver
Muhammad RN, Aborehab NM, Aly SH, Nasr NN, Hindam MO, Mustafa AM, et al. Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases. Inflammopharmacology. 2026;34(2):883-918. doi:10.1007/s10787-025-02069-2
BibTeX
@article{Muhammad2026,
author = {Muhammad, Radwa N and Aborehab, Nora M and Aly, Shaza H and Nasr, Noha N and Hindam, Merhan O and Mustafa, Aya M and Faheem, Safaa A and Fawzy, Mariam H and Abo-El Fetoh, Mohammed E and El-Dessouki, Ahmed M and Rabie, Mostafa A and El-Shiekh, Riham A and Youssef, Mahmoud E},
title = {Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases},
journal = {Inflammopharmacology},
year = {2026},
volume = {34},
number = {2},
pages = {883--918},
doi = {10.1007/s10787-025-02069-2}
}
EUVIMED